Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system

BackgroundLinear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disease. The induction of LABD by medications is a critical issue, with previous studies highlighting the link between specific drugs and the onset of LABD. This study aims to assess the reported associations between LABD...

詳細記述

書誌詳細

主要な著者:	Yixuan Yang, Hanzhang Xie, Shuhan Liu, Ying Jia, Bingnan Cui, Zhanshuo Xiao
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2025-01-01
シリーズ:	Frontiers in Medicine
主題:	linear IgA bullous dermatosis drug-induced linear IgA bullous dermatosis adverse event FAERS pharmacovigilance study
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1521697/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!